These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25102485)

  • 1. Allergy and immunology.
    Assa'ad A
    Pediatr Ann; 2014 Aug; 43(8):312. PubMed ID: 25102485
    [No Abstract]   [Full Text] [Related]  

  • 2. [YEAR IN REVIEW OF NASAL ALLERGY: SUBLINGUAL IMMUNOTHERAPY].
    Masuyama K
    Arerugi; 2015 Sep; 64(9):1210-4. PubMed ID: 26657909
    [No Abstract]   [Full Text] [Related]  

  • 3. Sublingual immunotherapy in children: the recent experiences.
    Pleskovic N; Bartholow A; Skoner DP
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):582-90. PubMed ID: 25188717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [SUBLINGUAL IMMUNOTHERAPY].
    Gotoh M
    Arerugi; 2015 Aug; 64(8):1136-40. PubMed ID: 26522415
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Applications of Sublingual Immunotherapy.
    Edwards TS; Wise SK
    Otolaryngol Clin North Am; 2017 Dec; 50(6):1121-1134. PubMed ID: 29103453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms.
    Mosbech H; Canonica GW; Backer V; de Blay F; Klimek L; Broge L; Ljørring C
    Ann Allergy Asthma Immunol; 2015 Feb; 114(2):134-40. PubMed ID: 25624131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Special focus: inflammatory diseases of the eye].
    Heiligenhaus A; Cursiefen C
    Klin Monbl Augenheilkd; 2014 May; 231(5):488-9. PubMed ID: 24799166
    [No Abstract]   [Full Text] [Related]  

  • 9. Current and future challenges of subcutaneous and sublingual allergy immunotherapy for allergists in the United States.
    Nelson HS
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):278-280. PubMed ID: 29409924
    [No Abstract]   [Full Text] [Related]  

  • 10. Allergy and Asthma: Allergic Rhinitis and Allergic Conjunctivitis.
    Mehta R
    FP Essent; 2018 Sep; 472():11-15. PubMed ID: 30152668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in the treatment of pediatric allergic rhinitis and conjunctivitis.
    Lierl MB
    Pediatr Ann; 2014 Aug; 43(8):e192-200. PubMed ID: 25102489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual grass and ragweed immunotherapy: Clinical considerations-a PRACTALL consensus report.
    Li JT; Bernstein DI; Calderon MA; Casale TB; Cox L; Passalacqua G; Pfaar O; Papadopoulos NG
    J Allergy Clin Immunol; 2016 Feb; 137(2):369-76. PubMed ID: 26371843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained improvement of psoriatic lesions in the course of sublingual immunotherapy for airborne allergens: clinical evidence of cross-tolerance.
    Theodoropoulos DS; Morris MS; Morris DL
    Eur Rev Med Pharmacol Sci; 2015; 19(3):392-5. PubMed ID: 25720708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites.
    Maloney J; Prenner BM; Bernstein DI; Lu S; Gawchik S; Berman G; Kaur A; Li Z; Nolte H
    Ann Allergy Asthma Immunol; 2016 Jan; 116(1):59-65. PubMed ID: 26553448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review.
    Didier A; Bons B
    Expert Opin Drug Saf; 2015 May; 14(5):777-88. PubMed ID: 25732009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, open, parallel-group study.
    Di Rienzo V; Cadario G; Grieco T; Galluccio AG; Caffarelli C; Liotta G; Pecora S; Burastero SE
    Ann Allergy Asthma Immunol; 2014 Dec; 113(6):671-673.e1. PubMed ID: 25304342
    [No Abstract]   [Full Text] [Related]  

  • 17. Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber.
    Nolte H; Maloney J; Nelson HS; Bernstein DI; Lu S; Li Z; Kaur A; Zieglmayer P; Zieglmayer R; Lemell P; Horak F
    J Allergy Clin Immunol; 2015 Jun; 135(6):1494-501.e6. PubMed ID: 25636947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual Immunotherapy for Allergic Rhinitis: Is 2-Year Treatment Sufficient for Long-term Benefit?
    Cox LS
    JAMA; 2017 Feb; 317(6):591-593. PubMed ID: 28196239
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study.
    Leonardi A; Castegnaro A; Valerio AL; Lazzarini D
    Curr Opin Allergy Clin Immunol; 2015 Oct; 15(5):482-8. PubMed ID: 26258920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing and managing allergic conjunctivitis in childhood: The allergist's perspective.
    Fauquert JL
    Pediatr Allergy Immunol; 2019 Jun; 30(4):405-414. PubMed ID: 30742722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.